Epstein Secrets

hould end by December 8." Politico adds Sens. Jim Risch (R-ID), Marco Rubio (R-FL), Lisa Murkowski (R-AK), Pat Toomey (R-PA), Susan Collins (R-ME), Mitt Romney (R-UT), Ben Sasse (R-NE), and Lamar Alexander (R-TN) have also "acknowledged the need for a transition." On CNBC's Squawk Box <https://playvideo.bu

), Pat Toomey (R-PA), Susan Collins (R-ME), Mitt Romney (R-UT), Ben Sasse (R-NE), and Lamar Alexander (R-

ealth- coronavirus-astrazeneca-oxford/decades-of-work-and-half-a-dose-of-fortune-drove-oxford-vaccine-success- idUSKBN2832NC> (11/23, Smout, Kelland, Burger) reports AstraZeneca "said it was a minor mistake that made the team realise how they could significantly boost the shot's success rate, to as much

you if you care about the rule of law." The Washington Times (7/12, Sherfinski, 492K) and Politico (7/12, Oprysko, 4.29M) cover Schiff's remarks. Romney, Toomey Join Democrats In Denouncing Stone Clemency, Graham And Rep. Jordan Back President's Move. On the CBS Weekend NewsVi (7/11, Story 3, 1:19,

Joe Biden to House Speaker Pelosi "accused the President of abuse of power. So did some Republicans." Bloomberg (7/11, Wasson, 4.73M) reports Sens. Mitt Romney (R-UT) and Pat Toomey (R- PA) "became the first major Republican elected officials to criticize...Trump's decision to commute" Stone's sentence. Rom

use What Donald Trump's 'Access Hollywood' Weekend Says About 2020 Disney World Opens Its Gates, With Virus Numbers Rising Washington Post: A $20 Burger's Pandemic Odyssey Florida Surge Shatters Record Democrats Sense Shift As Trump's Polls Drop Green Goal: Hottest City Finds Ways To Get Cool In T

r 8." Politico adds Sens. Jim Risch (R- ID), Marco Rubio (R-FL), Lisa Murkowski (R-AK), Pat Toomey (R-PA), Susan Collins (R-ME), Mitt EFTA00149132 Romney (R-UT), Ben Sasse (R-NE), and Lamar Alexander (R-TN) have also "acknowledged the need for a transition." On CNBC's Squawk BoxVI (11/23, 114K), Sen.

g two full doses one month apart was 62% effective." Combined, the data indicated "an average efficacy rate of 70%." Reuters (11/23, Smout, Kelland, Burger) reports AstraZeneca "said it was a minor mistake that made the team realise how they could significantly boost the shot's success rate, to as much